Skip to content

Tinea Pedis (Athlete’s Foot)

BASICS

DESCRIPTION

  • Most common dermatophyte infection
  • Contagious, especially in communal environments
  • Frequently associated with:
  • Tinea manuum
  • Tinea cruris
  • Tinea unguium
  • Clinical forms:
  • Interdigital (most common)
  • Hyperkeratotic (moccasin type)
  • Vesiculobullous type

EPIDEMIOLOGY

  • Age: 20–50 years (can occur at any age)
  • Gender: ♂ > ♀ (4:1)
  • Prevalence:
  • ~4–10% active at any given time
  • 70% will experience it during lifetime

Pediatric Considerations

  • Rare in young children
  • More common post-puberty

Geriatric Considerations

  • More common due to:
  • Reduced immunity
  • Poor distal perfusion

ETIOLOGY & PATHOPHYSIOLOGY

  • Dermatophytes infect only nonviable keratinized tissue
  • Common organisms:
  • Trichophyton rubrum (chronic)
  • Trichophyton interdigitale (acute)
  • Trichophyton tonsurans
  • Epidermophyton floccosum
  • No known genetic pattern

RISK FACTORS

  • Hot, humid environments
  • Excessive sweating
  • Occlusive footwear
  • Immunosuppression
  • Chronic topical steroid use

PREVENTION

  • Personal hygiene
  • Use of sandals in shared wet areas
  • Dry feet thoroughly, especially between toes
  • Frequent sock changes
  • Antiperspirants or drying powders
  • Antifungal shoe sprays or powders

COMMON ASSOCIATIONS

  • Onychomycosis
  • Tinea cruris
  • Tinea manuum
  • Hyperhidrosis

DIAGNOSIS

HISTORY

  • Pruritic, scaling rash on foot, typically interdigital
  • May involve:
  • Soles, dorsum, sides of feet
  • Strong odor, maceration, ulceration
  • Secondary bacterial infection or dermatophytid reaction possible

PHYSICAL EXAM

  • Acute: scaling, redness, white maceration between toes
  • Chronic (moccasin type): erythema, scaling of soles and sides of feet
  • May be bilateral or unilateral

DIFFERENTIAL DIAGNOSIS

  • Interdigital:
  • Erythrasma
  • Impetigo
  • Candidal intertrigo
  • Pitted keratolysis
  • Moccasin type:
  • Psoriasis
  • Contact dermatitis
  • Chronic eczema
  • Vesiculobullous:
  • Dyshidrotic eczema
  • Bullous impetigo
  • Autoimmune blistering diseases

DIAGNOSTIC TESTS

  • KOH microscopy: branching hyphae
  • Fungal culture (Sabouraud agar) if unclear diagnosis
  • PCR: for resistant/recurrent cases
  • Wood’s lamp: Not helpful for T. rubrum

TREATMENT

TOPICAL ANTIFUNGALSFirst-Line for Local Disease

Agent Dose/Frequency Duration
Terbinafine 1% BID Until 3 days after rash clears
Econazole 1% BID 2–4 weeks
Ketoconazole 2% BID 2–4 weeks
Tolnaftate 1% BID 2–4 weeks
Aluminum acetate soaks 20 min BID For vesiculobullous type
Aluminum chloride 30% BID For hyperhidrosis

Continue topical antifungals for at least 3 days beyond clinical resolution.


SYSTEMIC ANTIFUNGALSFor Severe, Extensive, or Nail Involvement

Drug Dose Notes
Itraconazole 200 mg BID × 7 days >90% cure
Fluconazole 150 mg weekly × 4 weeks Alternative
Terbinafine 250 mg/day × 2–6 weeks Also for onychomycosis
Griseofulvin 250–500 mg/day × 3 weeks Second-line; monitor LFTs

⚠ Monitor LFTs with systemic therapy
⚠ Itraconazole: avoid in CHF, use with acidic drinks if on PPIs
⚠ Griseofulvin: avoid in porphyria, SLE, or liver disease


PEDIATRIC DOSING

Drug Weight-based dosing
Griseofulvin 10–15 mg/kg/day
Terbinafine <20 kg: 62.5 mg/day
20–40 kg: 125 mg/day
>40 kg: 250 mg/day
Itraconazole 3–5 mg/kg/day
Fluconazole 6 mg/kg/week

ADJUNCTIVE & ALTERNATIVE THERAPIES

  • Baking soda soaks (½ cup/quart water)
  • White vinegar soaks (1:1 vinegar:water) – for bacterial coinfection
  • Eczematoid changes: topical corticosteroids
  • Secondary bacterial infections: topical/systemic antibiotics

REFERRAL

  • Dermatology referral if:
  • Extensive/refractory disease
  • Immunocompromised host
  • Diagnosis in doubt

ONGOING CARE & FOLLOW-UP

  • Monitor for recurrence
  • Educate on:
  • Hygiene
  • Footwear habits
  • Sock-changing frequency
  • Prevent tinea cruris by:
  • Wearing socks before underwear
  • Treating all affected sites simultaneously

PROGNOSIS

  • Often chronic or recurrent
  • Requires long-term prevention strategies
  • Recurrences common in hot, humid climates

COMPLICATIONS

  • Secondary bacterial infection: risk of cellulitis, lymphangitis
  • Dermatophytid reaction (id reaction)
  • Chronic hyperkeratosis
  • Spread to nails (onychomycosis)

ICD-10 CODE

  • B35.3 – Tinea Pedis

CLINICAL PEARLS

  • Treat for 4 weeks minimum
  • Dry feet well, especially between toes
  • Dusting powders help prevent recurrence
  • Consider fungal infection in recalcitrant eczema of the foot
  • Always check for concomitant onychomycosis or tinea cruris